U.S. District Judge William Pauley sentenced Samuel Waksal, founder and former chief executive of ImClone Systems, on Tuesday to 87 months in prison, and ordered him to pay $3 million in fines, plus $1.26 million in restitution. Pauley condemned Waksal for the damage he caused to society including the cancer patients who are still awaiting […]
Entries from June 2003
ImClone Founder Gets 87 Months in the Slammer
June 11th, 2003 · 5 Comments
Tags: Uncategorized
Court: Consumers can switch carriers and keep mobile-numbers
June 9th, 2003 · 1 Comment
Mobile-phone customers may be able to switch to new providers and keep their phone numbers, the U.S. Court of Appeals for the District of Columbia ruled Friday and upheld an earlier decision by the Federal Communications Commission. The court’s three-judge panel said the rule was needed because companies would not likely offer the option on […]
Tags: Uncategorized
Verizon to Reveal Identity of Alleged MP3 Traders in Piracy Case
June 5th, 2003 · No Comments
Verizon Communications said it would turn over the names of four online subscribers accused of distributing hundreds of songs online over to the Recording Industry Association of America after a U.S. appeals court declined to interfere.
“Verizon remains concerned that the R.I.A.A. and other copyright owners and people who are not copyright owners may abuse this […]
Tags: Piracy
FDA Issues Alert Over Recall of Med-Pro, Counterfeit Lipitor
June 3rd, 2003 · 4 Comments
The Food and Drug Administration (FDA) today announced that Albers Medical Distributors, Inc., has voluntarily recalled three lots of 90-count bottles of the cholesterol-lowering drug Lipitor and is warning healthcare providers and others that these three lots of counterfeit Lipitor represent a potentially significant risk to consumers. The product was repackaged by Med-Pro, Inc., of […]
Tags: Lipitor
Ephedra: Cytodyne to Pay $12.5 Million in ‘Xenadrine’ case
June 2nd, 2003 · No Comments
San Diego Superior Court Judge Ronal Styn found Cytodyne Technologies, Inc., maker of the dietary supplement Xenadrine RFA-1, liable in a class-action consumer fraud lawsuit and ordered the company to pay $12.5 million for making exaggerated and false claims about Xenadrine’s safety and effectiveness.
“The decision is a victory for the consumers in California, and […]
Tags: Uncategorized

